Past Events

Applications Now Open for the BenDaniel Venture Challenge  

The BenDaniel Venture Challenge (BVC) is Big Red Venture’s Annual Pitch Competition. BRV will select five finalists to pitch their business ideas to a panel of investors during Entrepreneurship at Cornell Celebration on April 12. Winners will earn a cash prize totaling $25,000 with an additional $25,000 match if the company’s technology is licensed through Cornell.   

Companies based in New York state or with a Cornell affiliation are eligible to apply. Applications are open through March 22, 2024. Apply now. 

Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants (BRIDGe). 

BRIDGe awards are designed to support academic researchers by providing funding and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. Projects eligible for BRIDGe awards include early lead optimization and IND-enabling studies, using small molecule approaches, anywhere in the world. Biologicals, including peptides or antibodies, oligonucleotides, cell and gene therapy applications and medical devices are not eligible at this time. Drug repurposing approaches are also not eligible during this funding cycle.

Please see attached documents for the  details of the funding opportunity and also a  pre-proposal template. To apply, send Deanna Scarcella (des4016@med.cornell.edu) a NON-CONFIDENTIAL (make sure to EXCLUDE any unpublished data or information) pre-proposal by Friday, March 22, 2024, which will be reviewed by the CTL. CTL will coordinate submitting the pre-proposal by the deadline of Fri, Mar 29. Contact Deanna if you have any questions. 

The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.

Award Terms

• The grant amount is $250,000 per year for three (3) years totaling $750,000.
• Indirect costs are not to exceed 10% of direct costs and are included in total.
• Emerging Leader Awards are granted to a single investigator; co-investigators are not permitted. The award may be used to support projects carried out with collaborators, who may provide letters of support.
• In Year 3, at The Mark Foundation’s discretion, select Awardees may be invited to apply for up to two (2) years of additional funding depending on project progress.
• The letter of agreement will include IP terms with a revenue sharing component.
• Award start date will be January 1, 2025.

The portal to submit letters of intent for the upcoming Emerging Leader Award will open on March 20, 2024. Letters of Intent must be submitted through the online application system no later than 5 PM Eastern Time on Monday, April 29, 2024. Learn more about the application process here. 

This panel discussion delves into data rights in AI-related technologies and strategies for successful commercialization. Panelists include Jason Novak of Norton Rose Fulbright, Fernando Gómez-Baquero, Director of the Runway Startup Postdoc and Spinout Programs, and Vince Hartman, Co-founder and CEO of Abstractive Health. This engaging session will offer a multifaceted view on leveraging AI technologies for commercial success, ensuring data rights, and navigating the evolving landscape of AI commercialization. Food and drink networking reception to follow! 

Register here.